Multidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statement

dc.contributor.authorOspina Serrano, Aylen Vanessa
dc.contributor.authorGonzález Larriba, José Luis
dc.contributor.authorNadal, Ernest
dc.contributor.authorHernando Trancho, Florentino
dc.contributor.authorBosch-Barrera, Joaquim
dc.contributor.authorCalvo, Virginia
dc.contributor.authorBolufer Nadal, Sergio
dc.contributor.authorCampo Cañaveral de la Cruz, José Luis
dc.contributor.authorMacía Vidueira, Iván
dc.contributor.authorÁlvarez Kindelán, Antonio
dc.contributor.authorBarco Morillo, Edel del
dc.contributor.authorBernabé Caro, Reyes
dc.contributor.authorCasal-Rubio, Joaquín
dc.contributor.authorCilleruelo Ramos, Ángel
dc.contributor.authorCobo Dols, Manuel
dc.contributor.authorDómine Gómez, Manuel
dc.contributor.authorFigueroa Almánzar, Santiago
dc.contributor.authorInsa Mollá, Amelia
dc.contributor.authorJarabo Sarceda, José Ramón
dc.contributor.authorJiménez Maestre, Unai
dc.contributor.authorLópez Castro, Rafael
dc.contributor.authorMajem, Margarita
dc.contributor.authorMartínez-Martí, Alex
dc.contributor.authorMartínez Téllez, Elisabeth
dc.contributor.authorSánchez-Lorente, David
dc.contributor.authorLópez Valcárcel, Marta
dc.contributor.authorCouñago, Felipe
dc.contributor.authorGarcía-Campelo, Rosario
dc.contributor.authorCastro, Javier de
dc.contributor.authorMassutí Sureda, Bartomeu
dc.contributor.authorProvencio, Mariano
dc.date.accessioned2025-11-13T10:34:01Z
dc.date.available2025-11-13T10:34:01Z
dc.date.issued2025-09-01
dc.date.updated2025-11-12T10:04:58Z
dc.description.abstractBackground: In light of the ongoing advancements in the treatment of patients with early- and locally advanced-stage non-small cell lung cancer (NSCLC), the members of the Spanish Lung Cancer Group (GECP) deemed it necessary to update its 2023 consensus suggestions for the management of these patients. Methods: From July to November 2024, a panel of experts, including thoracic surgeons, radiation oncologists, and medical oncologists, was convened. The consensus process was developed using a mixed approach that incorporated Delphi and nominal group techniques. The consensus coordination group reviewed the relevant scientific literature for the update and developed a questionnaire for the panel of experts to vote on. Two rounds of voting were conducted, followed by a final nominal group meeting to discuss clinical situations where consensus had not been reached and draw final conclusions. In instances where high-quality scientific data were not available or were the subject of controversy, final suggestions were based on the expertise of the participants. Results: Thirty experts from the multidisciplinary team participated in the voting and discussions. The document was updated to incorporate recent advancements in molecular diagnosis and biomarkers, the role of the multidisciplinary thoracic committee, criteria for neoadjuvant/perioperative treatment, approaches to inoperable/unresectable disease, and adjuvant treatment. Proposals that did not require updating were not voted on again and remain part of the document, maintaining their first version. Conclusions: Updated suggestions were developed for the most relevant situations in the treatment of patients with early-stage and locally advanced NSCLC. These suggestions will support clinical decisionmaking in daily practice. This paper presents the statements developed by the expert panel and summarizes the scientific evidence supporting them.
dc.format.extent24 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2226-4477
dc.identifier.pmid41132973
dc.identifier.urihttps://hdl.handle.net/2445/224340
dc.language.isoeng
dc.publisherAME Publishing Company
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.21037/tlcr-2025-619
dc.relation.ispartofTranslational Lung Cancer Research, 2025, vol. 14, num. 9, 3299-3322
dc.relation.urihttps://doi.org/10.21037/tlcr-2025-619
dc.rightscc-by-nc-nd (c) ME Publishing Company, 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationMetàstasi
dc.subject.classificationFarmacologia respiratòria
dc.subject.classificationOncologia
dc.subject.otherMetastasis
dc.subject.otherPulmonary pharmacology
dc.subject.otherOncology
dc.titleMultidisciplinary approach for patients with early and locally advanced non-small cell lung cancer (NSCLC): 2nd Spanish Lung Cancer Group (GECP) expert consensus statement
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
tlcr-14-09-3299.pdf
Mida:
609.52 KB
Format:
Adobe Portable Document Format